Skip to search formSkip to main contentSkip to account menu

Leuplin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Leuplin is a drug for the treatment of prostate cancer. It is a sustained-release injectable formulation of leuprorelin acetate… 
2017
2017
The adult height of children with early onset puberty is limited by the premature maturation of hypothalamic-pituitary-gonadal… 
2007
2007
To reduce chemotherapy induced gonadotoxicity, co-treatment with gonadotropin releasing hormone against analogue (GnRHa) was… 
2006
2006
Objective Recently, skin reactions to luteinizing hormone-releasing hormone (LH-RH) agonist therapy were reported after the 3… 
2003
2003
This study aimed to examine the activation of poly(ADP-ribose) polymerase (PARP) and the accumulation of its end product, poly… 
2002
2002
GnRH agonist (GnRH-a) therapy is known to shrink uterine leiomyoma, although the molecular mechanisms responsible for this effect… 
2001
2001
BACKGROUND/PURPOSE Twenty-two institutes have organized Keio University Prostate Cancer Study Group to study clinical efficacy…